Keyphrases
Disease Progression
100%
Cell Proliferation
100%
Cell Toxicity
100%
Chronic Myeloid Leukemia
100%
Lymphokine-activated Killer Cells
100%
Cell-to-cell
60%
Leukemia Patients
40%
Lysis
40%
Chronic Phase
35%
Early Chronic Phase
35%
K562
30%
Cytotoxicity
25%
Raji
20%
Natural Killer Cells
15%
Cytotoxic Activity
15%
Advanced Disease
10%
Recombinant interleukin-2
10%
Proliferative Activity
10%
Peripheral Blood Natural Killer Cells
10%
Cell Culture
5%
T Cells
5%
Peripheral Blood Mononuclear Cells
5%
Leukemia
5%
Gene Rearrangement
5%
Malignant Transformation
5%
Interleukin-2
5%
Cell Population
5%
CD56
5%
Natural Killer
5%
Peripheral Blood
5%
Disease Stage
5%
Cytotoxicity Assay
5%
Mononuclear Cells
5%
CD56+
5%
Effector Target
5%
Selective Enrichment
5%
Proliferative Potential
5%
Ph-positive
5%
CD3+
5%
Prolonged Duration
5%
Large Granular Lymphocyte
5%
Uniform Generation
5%
Hyperproliferative
5%
Cell Culture Method
5%
Medicine and Dentistry
Disease Exacerbation
100%
Chronic Myelogenous Leukemia
100%
Lymphokine Activated Killer Cell
100%
Cytotoxicity
100%
Natural Killer Cell
20%
Diseases
20%
Recombinant Interleukin 2
10%
CD3 Antigen
10%
Cell Culture
10%
Gene Rearrangement
5%
Killer Cell
5%
T Lymphocyte
5%
Cell Population
5%
Mononuclear Cell
5%
Malignant Transformation
5%
Cytotoxicity Assay
5%
Large Granular Lymphocyte
5%
Leukemia
5%
Interleukin 2
5%
Peripheral Blood Mononuclear Cell
5%
Immunology and Microbiology
Cytotoxicity
100%
Lymphokine Activated Killer Cell
100%
Natural Killer Cell
20%
Recombinant Interleukin 2
10%
CD3 Antigen
10%
Large Granular Lymphocyte
5%
Cell Culture
5%
Interleukin 2
5%
Killer Cell
5%
Cell Population
5%
Gene Rearrangement
5%
Mononuclear Cell
5%
Cell Culture Technique
5%
T Cell
5%
Peripheral Blood Mononuclear Cell
5%
Biochemistry, Genetics and Molecular Biology
Cytotoxicity
100%
Lymphokine
100%
Natural Killer Cell
20%
Interleukin 2
15%
Cytotoxicity Assay
5%
Cell Culture
5%
Gene Rearrangement
5%
Cell Culture Technique
5%
Peripheral Blood Mononuclear Cell
5%
T Cell
5%
K562 Cells
5%
Malignant Transformation
5%
Lymphocyte
5%